These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1265 related articles for article (PubMed ID: 15181114)

  • 1. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 2. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 3. USP publishes enforceable chapter on sterile compounding.
    Thompson CA
    Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028
    [No Abstract]   [Full Text] [Related]  

  • 4. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exemption of radiopharmaceuticals from <797>.
    Hung JC; VanBrocklin HF
    J Nucl Med; 2004 Oct; 45(10):14N. PubMed ID: 15551510
    [No Abstract]   [Full Text] [Related]  

  • 6. From the SNM Committee on Pharmacopeia: Exemption of radiopharmaceuticals from <797>.
    Hung JC;
    J Nucl Med; 2004 Oct; 45(10):13N, 16N. PubMed ID: 15551509
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 9. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.
    Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622
    [No Abstract]   [Full Text] [Related]  

  • 10. Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2.
    Martin M
    Int J Pharm Compd; 2018; 22(6):475-478. PubMed ID: 30384348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisions continue on USP sterile-compounding chapter.
    Thompson CA
    Am J Health Syst Pharm; 2005 Sep; 62(18):1856, 1858, 1861-2. PubMed ID: 16141100
    [No Abstract]   [Full Text] [Related]  

  • 12. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 13. Codes + standards. Pharmacy facts. Architectural and environmental changes required for USP 797.
    Bernstein WN
    Health Facil Manage; 2005 Jul; 18(7):39-40. PubMed ID: 16130375
    [No Abstract]   [Full Text] [Related]  

  • 14. Joint commission to survey compliance with new USP-NF Chapter on compounding sterile preparations.
    Jt Comm Perspect; 2004 Apr; 24(4):4-5. PubMed ID: 15085694
    [No Abstract]   [Full Text] [Related]  

  • 15. United States Parmacopeia Chapter <797> timeline: 1989 to 2013.
    Newton DW
    Int J Pharm Compd; 2013; 17(4):283-8. PubMed ID: 24261142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.
    Kastango ES; Bradshaw BD
    Am J Health Syst Pharm; 2004 Sep; 61(18):1928-38. PubMed ID: 15487884
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of newly revised sterile medication compounding guidelines USP {797} on allergy vial preparation.
    Lin SY; Houser SM; Gross G; Aaronson D
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):5-6. PubMed ID: 18585553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blueprint for implementing USP chapter 797 for compounding sterile preparations.
    Kastango ES;
    Am J Health Syst Pharm; 2005 Jun; 62(12):1271-88. PubMed ID: 15947127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The essentials of United States Pharmacopeia Chapter <51> antimicrobial effectiveness testing and its application in pharmaceutical compounding.
    Vu N; Nguyen K; Kupiec TC
    Int J Pharm Compd; 2014; 18(2):123-30. PubMed ID: 24881116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.